2 completed, 1 active not recruiting. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Ecopipam Hydrochloride: new trials by email Literature Review of Ecopipam Hydrochloride trials Research Report on Ecopipam Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder Ecopipam - Tourette Syndrome | Phase 3 | Active not recruiting | Emalex Biosciences Inc. | 150 | 2023-08-16 | 2026-07-22 |
| Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization Ecopipam Hydrochloride, Moxifloxacin, Placebo - QT/QTc | Phase 1 | Completed | Emalex Biosciences Inc. | 29 | 2023-03-15 | 2023-06-09 |
| Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults Ecopipam Hydrochloride - Tourette Disorder | Phase 3 | Completed | Emalex Biosciences Inc. | 216 | 2023-01-31 | 2026-06-12 |
Tourette Syndrome (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Mental Disorders (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neurodevelopmental Disorders (1) · Tic Disorders (1)
United States (3) · Bulgaria (2) · Canada (2) · Hungary (2) · Italy (2) · Poland (2) · Serbia (2) · Spain (2) · Denmark (1) · France (1) · Germany (1) · Romania (1)
2023 (2)